PRECISEU Matchmaking Platform

20 Oct 2025 – 31 Jan 2026 | Barcelona, Spain

Register
Register
Register

SYNOESIS THERAPEUTICS LTD

SME

synoesis-therapeutics.comHeraklion, Greece
5 profile visits

About

SyNoesis Therapeutics is a precision-medicine SME integrating AI-enabled clinical decision-support, multimodal biomarkers, and therapeutic development to improve the early detection and management of chronic and neurological diseases, and advance First-in-Class treatments.

On the digital-health side, SyNoesis has developed a TRL6 clinical-note NLP engine validated on large, real-world, multilingual EHR datasets, supporting early risk stratification and personalised care. This expertise is being expanded by integrating functional and molecular biomarkers to build multimodal decision-support companions that can be deployed into routine clinical workflows.

In parallel, SyNoesis advances a focused preclinical drug development pipeline in neurodegeneration (and selected oncology indications), allowing mechanistic insights and biomarker discoveries to directly inform its AI-driven stratification tools. Through this integrated strategy, SyNoesis aims to contribute to equitable, data-driven personalised medicine and scalable clinical implementation across European regions.

Type of Cooperation

Research collaborationCo-developmentClinical validationConsortium partners

Sector

Health dataAIDiagnostics

Development Stage (TRL)

TRL 6

Therapeutic Area

BioinformaticsDiseases of the nervous system / neurologyEndocrine/nutritional/metabolic diseasesMental and behavioural disorders / psychiatry / psychologyProteomics

Representatives

CEO

SYNOESIS THERAPEUTICS LTD

Marketplace (1)